Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cell Therapy
Sort By
Newest First
1 / 3
Clinical Trials
OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster
OncoResponse
PR-10-24-NI-73
Nov 05, 2024
Biopreservation
Why Storage and Quality Go Hand-in-Hand in Advancing Therapies
Vitrafy
PAO-10-24-RTM-02
Nov 04, 2024
Cell Therapy
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
Cryoport
PR-10-24-NI-56
Oct 22, 2024
Cell Therapy
Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
Justin Irizarry, CFA
OrganaBio
PAO-09-24-CL-11
Sep 30, 2024
Cell Therapy
Facilitating Organoid Production for Biopharmaceutical Applications
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-12
Jul 02, 2024
Cell Therapy
Intelligent Cell Processing Enables Consistent, Reproducible, and Scalable GMP-Compliant Processes
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-07
May 30, 2024
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Genezen
PR-M03-24-01-5831
Mar 06, 2024
Cell Therapy Manufacturing
Rethinking Cell Engineering for Cell Therapy Manufacturing
Todd Sulchek, Ph.D
CellFE
PAO-11-23-CL-03
Dec 13, 2023
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
CRB
PR-M10-23-05
Oct 19, 2023
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Sarah Meeks, Ph.D.
MaxCyte
PAO-09-23-CL-09
Sep 28, 2023
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04
Sep 05, 2023
Cord Blood Bank Alliance
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
Be The Match BioTherapies
PR-M07-23-01
Jul 13, 2023
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Denis Dufrane, M.D., Ph.D.
PAO-03-23-CL-06
Mar 20, 2023
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
Terumo Blood and Cell Technologies
PR-M02-23-03
Feb 23, 2023
Cell Therapy
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-23-NI-01
Jan 31, 2023
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
Ryan Larson, Ph.D.
PAO-12-022-CL-04
Jan 03, 2023
Cell Therapy
Bedside Cell Therapies: Point-of-Care Manufacturing Is Slowly Becoming a Reality
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-022-NI-08
Nov 15, 2022
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06
Nov 11, 2022
iPSCs
Resolution Therapeutics and CCRM Sign Collaboration Agreement to Develop and Scale Up Manufacturing for Induced Pluripotent Stem Cell (iPSC)-Derived Macrophage Cell Therapies
CCRM
PR-M11-22-04
Nov 07, 2022
Cell Therapy
Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making
Chris McClain
Be The Match BioTherapies
PAO-11-022-CL-01
Nov 01, 2022
1 / 3
